Drug Shortage Report for APO-SUMATRIPTAN

Last updated on 2021-02-05 History
Report ID 131889
Drug Identification Number 02268396
Brand name APO-SUMATRIPTAN
Common or Proper name SUMATRIPTAN
Company Name APOTEX INC
Market Status MARKETED
Active Ingredient(s) SUMATRIPTAN
Strength(s) 100MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 6 BLS
ATC code N02CC
ATC description ANTIMIGRAINE PREPARATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-01-11
Estimated end date 2021-02-07
Actual end date 2021-02-03
Shortage status Resolved
Updated date 2021-02-05
Company comments
Health Canada comments
Contact Address 150 SIGNET DRIVE
TORONTO, ONTARIO
CANADA M9L 1T9
Company contact information Apotex Customer Service - 1-877-427-6839

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v5 2021-02-05 French Compare
v4 2021-02-05 English Compare
v3 2021-02-05 English Compare
v2 2021-01-18 French Compare
v1 2021-01-18 English Compare